NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE196709 Query DataSets for GSE196709
Status Public on Dec 01, 2022
Title 5-Fluorouridine restores functional full-length p53 in TP53 nonsense mutant human tumor cells (Ribo-Seq)
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Other
Summary The tumor suppressor gene TP53 is mutated in approximately half of all human tumors. Of those, around 10% are nonsense mutations that produce truncated and inactive p53 protein. Induction of translational readthrough is a promising approach for rescuing full-length p53 and thereby eliminate tumor cells with nonsense mutant TP53. To find novel nonsense mutant TP53 readthrough-inducing compounds with a tolerable toxicity profile, we performed an in silico screening of data at the National Cancer Institute database and identified 5-Fluorouracil (5-FU). We show here that 5-FU induces full-length p53 in human tumor cells carrying R213X nonsense mutant TP53 and that this activity is mediated by its metabolite 5-Fluorouridine (FUr). Ribo-seq analysis validated induction of translational readthrough by FUr. We also show that FUr is incorporated into RNA where it potentially allows base pairing of Arg tRNA at the R213X UGA premature termination codon. Full-length p53 rescued by FUr is transcriptionally active and triggers p53-dependent cell death. Moreover, treatment with 5-FU or FUr restores full-length p53 expression in TP53 R213X mutant human tumor xenografts in vivo. Our results suggest that induction of readthrough by 5-FU/FUr could contribute to therapeutic efficacy in patients with TP53 nonsense mutant tumors.
 
Overall design Ribo-seq analysis of readthrough in three conditions (Untreated, FUr, G418) in empty vector and R213X vector. Four replicates per group.
 
Contributor(s) Palomar-Siles M, Heldin A, Zhang M, Strandgren C, Yurevych V, van Dinter JT, Engels S, Hofman DA, Öhlin S, Meineke B, Bykov VN, van Heesch S, Wiman KG
Citation(s) 36433934
Submission date Feb 14, 2022
Last update date Dec 01, 2022
Contact name Sebastiaan van Heesch
E-mail(s) S.vanheesch@prinsesmaximacentrum.nl
Organization name Princess Maxima Center
Lab van Heesch
Street address Heidelberglaan 25
City Utrecht
ZIP/Postal code 3584 CS
Country Netherlands
 
Platforms (1)
GPL30173 NextSeq 2000 (Homo sapiens)
Samples (24)
GSM5899098 Ribo-Seq H1299-EV-1
GSM5899099 Ribo-Seq H1299-EV-3
GSM5899100 Ribo-Seq H1299-EV-4
This SubSeries is part of SuperSeries:
GSE196712 5-Fluorouridine restores functional full-length p53 in TP53 nonsense mutant human tumor cells
Relations
BioProject PRJNA806946

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE196709_ribo_counts_matrix.txt.gz 556.1 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap